Showing results (71-80 of 98) with videos related to
Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumabAndrea Sartore-Bianchi, Mauro Moroni, Silvio Veronese, et al.Lancet (London, England)|June 3, 2008
Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II studyJean-Philippe Spano, Catherine Chodkiewicz, Joan Maurel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Randomized, placebo-controlled, phase III study of oxaliplatin, fluorouracil, and leucovorin with or without PTK787/ZK 222584 in patients with previously treated metastatic colorectal adenocarcinomaEric Van Cutsem, Emilio Bajetta, Juan Valle, et al.Lancet (London, England)|December 25, 2007
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trialBernard Escudier, Anna Pluzanska, Piotr Koralewski, et al.Cancer|October 21, 2006
Lanreotide autogel every 6 weeks compared with Lanreotide microparticles every 3 weeks in patients with well differentiated neuroendocrine tumors: a Phase III StudyEmilio Bajetta, Giuseppe Procopio, Laura Catena, et al.Journal of Experimental & Clinical Cancer Research : CR|January 16, 2014
Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programmeMaresa Altomonte, Anna Di Giacomo, Paola Queirolo, et al.Journal of Experimental & Clinical Cancer Research : CR|November 3, 2012
The cost of unresectable stage III or stage IV melanoma in ItalyMichele Maio, Paolo Ascierto, Alessandro Testori, et al.Cancer|January 13, 2004
Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinomaEmilio Bajetta, Maria Di Bartolomeo, Luigi Mariani, et al.BJU International|May 24, 2011
Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient casesCamillo Porta, Giuseppe Procopio, Giacomo Cartenì, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2007
Informal caregiving burden in advanced non-small cell lung cancer: the HABIT studyCesare Gridelli, Carmine Ferrara, Ciro Guerriero, et al.Pageof 10